Probing TDP-43 condensation using an in silico designed aptamer.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
23 06 2022
Historique:
received: 05 10 2021
accepted: 23 05 2022
entrez: 23 6 2022
pubmed: 24 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

Aptamers are artificial oligonucleotides binding to specific molecular targets. They have a promising role in therapeutics and diagnostics but are often difficult to design. Here, we exploited the catRAPID algorithm to generate aptamers targeting TAR DNA-binding protein 43 (TDP-43), whose aggregation is associated with Amyotrophic Lateral Sclerosis. On the pathway to forming insoluble inclusions, TDP-43 adopts a heterogeneous population of assemblies, many smaller than the diffraction-limit of light. We demonstrated that our aptamers bind TDP-43 and used the tightest interactor, Apt-1, as a probe to visualize TDP-43 condensates with super-resolution microscopy. At a resolution of 10 nanometers, we tracked TDP-43 oligomers undetectable by standard approaches. In cells, Apt-1 interacts with both diffuse and condensed forms of TDP-43, indicating that Apt-1 can be exploited to follow TDP-43 phase transition. The de novo generation of aptamers and their use for microscopy opens a new page to study protein condensation.

Identifiants

pubmed: 35739092
doi: 10.1038/s41467-022-30944-x
pii: 10.1038/s41467-022-30944-x
pmc: PMC9226187
doi:

Substances chimiques

DNA-Binding Proteins 0
Oligonucleotides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3306

Subventions

Organisme : Medical Research Council
ID : MC_EX_MR/N50192X/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M010996/1
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Lancet Neurol. 2016 Oct;15(11):1182-94
pubmed: 27647646
Biophys Rev. 2014 Mar;6(1):97-110
pubmed: 28509960
Cancer Res. 2021 Jan 1;81(1):103-113
pubmed: 33158813
Nature. 1990 Aug 30;346(6287):818-22
pubmed: 1697402
Nat Struct Mol Biol. 2013 Dec;20(12):1443-9
pubmed: 24240615
Nat Biotechnol. 1999 Jul;17(7):691-5
pubmed: 10404163
Nat Commun. 2014 Sep 12;5:4824
pubmed: 25215604
Nature. 2020 Jul;583(7818):711-719
pubmed: 32728246
RNA. 2013 Feb;19(2):129-40
pubmed: 23264567
Cell. 2011 Jan 7;144(1):67-78
pubmed: 21215370
Proteomics Clin Appl. 2012 Dec;6(11-12):563-73
pubmed: 23090891
Front Mol Neurosci. 2018 Oct 09;11:372
pubmed: 30356856
Cell Death Dis. 2020 Jul 13;11(7):527
pubmed: 32661334
Nucleic Acids Res. 2020 Nov 18;48(20):11270-11283
pubmed: 33068416
J Mol Biol. 2019 Apr 5;431(8):1671-1688
pubmed: 30742796
PLoS One. 2009 Nov 10;4(11):e7694
pubmed: 19901993
Nature. 1990 Mar 29;344(6265):467-8
pubmed: 1690861
Bioinformatics. 2020 Feb 1;36(3):940-941
pubmed: 31504168
Nucleic Acids Res. 2021 Jul 2;49(W1):W72-W79
pubmed: 34086933
Nat Methods. 2016 Dec 29;14(1):5-6
pubmed: 28032625
J Mol Biol. 2010 Jul 16;400(3):579-88
pubmed: 20416322
Neuron. 2019 Apr 17;102(2):321-338.e8
pubmed: 30826182
Sci Rep. 2015 Nov 19;5:16696
pubmed: 26582456
Bioinformatics. 2013 Apr 1;29(7):845-54
pubmed: 23407358
Molecules. 2019 Mar 07;24(5):
pubmed: 30866536
Nucleic Acids Res. 2013 Jan 7;41(1):e31
pubmed: 23093590
J Biol Chem. 2001 Sep 28;276(39):36337-43
pubmed: 11470789
Front Mol Biosci. 2020 Jun 03;7:104
pubmed: 32582762
Aging Cell. 2021 May;20(5):e13326
pubmed: 33788386
ACS Chem Neurosci. 2016 Mar 16;7(3):399-406
pubmed: 26800462
Nat Methods. 2011 Jun;8(6):444-5
pubmed: 21623348
Nucleic Acids Res. 2017 Jul 3;45(W1):W365-W373
pubmed: 28521030
Cell Rep. 2015 Jun 23;11(11):1760-71
pubmed: 26051935
Int J Mol Sci. 2020 Nov 10;21(22):
pubmed: 33182550
Science. 1990 Aug 3;249(4968):505-10
pubmed: 2200121
EMBO J. 2011 Jan 19;30(2):277-88
pubmed: 21131904
Anal Chem. 2012 Jul 3;84(13):5542-7
pubmed: 22697251
Nat Neurosci. 2011 Apr;14(4):452-8
pubmed: 21358640
J Exp Med. 2017 Dec 4;214(12):3481-3495
pubmed: 29141869
Nat Protoc. 2017 Jun;12(6):1198-1228
pubmed: 28518172
Anal Chem. 2015 Sep 1;87(17):8818-26
pubmed: 26258431
Nat Commun. 2019 Jul 19;10(1):3246
pubmed: 31324771
Protein Sci. 2013 Dec;22(12):1808-11
pubmed: 24127340
Nucleic Acids Res. 2017 Dec 15;45(22):12888-12903
pubmed: 29149290
Nucleic Acids Res. 2019 Jan 8;47(D1):D601-D606
pubmed: 30445601
Acta Neuropathol. 2007 Jul;114(1):63-70
pubmed: 17492294
Histochem Cell Biol. 2014 Jun;141(6):577-85
pubmed: 24509806
Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8486-8493
pubmed: 32234785
Mol Ther Nucleic Acids. 2019 Dec 6;18:99-109
pubmed: 31541799
Proteins. 1991;11(3):205-17
pubmed: 1749773
Mol Biosyst. 2012 Nov;8(11):2839-44
pubmed: 22868714
Chembiochem. 2018 Oct 4;19(19):2033-2038
pubmed: 30051958
Commun Biol. 2020 Sep 2;3(1):484
pubmed: 32879439
Nucleic Acids Res. 2016 Jul 8;44(W1):W315-9
pubmed: 27095203
Science. 2013 Aug 9;341(6146):655-8
pubmed: 23845946
Biotechnol Adv. 2013 Dec;31(8):1260-74
pubmed: 23632375
Nucleic Acids Res. 2009 Apr;37(6):1799-808
pubmed: 19174564
Nat Methods. 2014 Mar;11(3):313-8
pubmed: 24487583
Mol Neurodegener. 2020 Aug 15;15(1):45
pubmed: 32799899
Nat Struct Mol Biol. 2018 Nov;25(11):1035-1046
pubmed: 30374086
J Microsc. 1993 Mar;169(3):375-382
pubmed: 33930978

Auteurs

Elsa Zacco (E)

Centre for Human Technologies (CHT), Istituto Italiano di Tecnologia (IIT), Via Enrico Melen, 83, 16152, Genova, Italy.

Owen Kantelberg (O)

EaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, EH9 3FJ, UK.

Edoardo Milanetti (E)

Department of Physics, Sapienza University, Piazzale Aldo Moro 5, 00185, Rome, Italy.
Center for Life Nanoscience, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.

Alexandros Armaos (A)

Centre for Human Technologies (CHT), Istituto Italiano di Tecnologia (IIT), Via Enrico Melen, 83, 16152, Genova, Italy.

Francesco Paolo Panei (FP)

Department of Physics, Sapienza University, Piazzale Aldo Moro 5, 00185, Rome, Italy.

Jenna Gregory (J)

UK Dementia Research Institute at University of Edinburgh, University of Edinburgh, Edinburgh bioQuarter, Chancellor's Building, 49 Little F, Edinburgh, UK.
Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, UK.

Kiani Jeacock (K)

EaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, EH9 3FJ, UK.

David J Clarke (DJ)

EaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, EH9 3FJ, UK.

Siddharthan Chandran (S)

UK Dementia Research Institute at University of Edinburgh, University of Edinburgh, Edinburgh bioQuarter, Chancellor's Building, 49 Little F, Edinburgh, UK.
Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, UK.

Giancarlo Ruocco (G)

Department of Physics, Sapienza University, Piazzale Aldo Moro 5, 00185, Rome, Italy.
Center for Life Nanoscience, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.

Stefano Gustincich (S)

Centre for Human Technologies (CHT), Istituto Italiano di Tecnologia (IIT), Via Enrico Melen, 83, 16152, Genova, Italy.

Mathew H Horrocks (MH)

EaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, EH9 3FJ, UK. mathew.horrocks@ed.ac.uk.

Annalisa Pastore (A)

UK Dementia Research Institute at the Maurice Wohl Institute of King's College London, London, SE5 9RT, UK. annalisa.pastore@crick.ac.uk.

Gian Gaetano Tartaglia (GG)

Centre for Human Technologies (CHT), Istituto Italiano di Tecnologia (IIT), Via Enrico Melen, 83, 16152, Genova, Italy. gian.tartaglia@iit.it.
Centre for Genomic Regulation (CRG), Dr. Aiguader 88, 08003, Barcelona, Spain. gian.tartaglia@iit.it.
Catalan Institution for Research and Advanced Studies, ICREA, Passeig Lluís Companys 23, 08010, Barcelona, Spain. gian.tartaglia@iit.it.
Department of Biology 'Charles Darwin', Sapienza University of Rome, P.le A. Moro 5, Rome, 00185, Italy. gian.tartaglia@iit.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH